Abstract

Effective isotretinoin safety monitoring in a pediatric dermatology patient population: A novel approach to symptom surveying patients

Author(s): Alexander Adisa

A random sample of patients who received isotretinoin treatment at a tertiary pediatric dermatology clinic completed an at each visit, so we reviewed their records retrospectively. Our objective was to determine the usefulness of an isotretinoin symptom survey as a screening tool for assessing and quantifying adverse effects, including psychiatric symptoms, during isotretinoin treatment in a pediatric population of various age groups. Responses were stratified according to age group and prior psychiatric history.